Profile

Cover photo
TCTMD - The Source for Interventional Cardiovascular News and Education
35 followers|13,144 views
AboutPostsYouTube

Stream

 
Episode 9: DAPT Duration, Triple Therapy After A-fib, and Use of PPIs.

This week's episode is hosted by E. Magnus Ohman and features guests Ori Ben-Yehuda, Deepak Bhatt, Clemens von Birgelen, Ricardo Costa, Saibal Kar, Duane Pinto, and Kenneth Rosenfield.

https://www.tctmd.com/audio/episode-9-dapt-duration-triple-therapy-after-fib-and-use-ppis

TCTMD is produced by the Cardiovascular Research Foundation (CRF). CRF is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients' lives. For more information, visit http://www.crf.org. Created by Constructive ...
1
Add a comment...
 
TCT Featured Slide: Structure and Function of the Coronary Circulation http://buff.ly/2gY1ffH
1
Add a comment...
 
Join Drs. Stone, Ajay Kirtane & Roxana Mehran now for a LIVE Webcast Ongoing Trials in PCI: Trying to Predict Results http://buff.ly/2gJOvxY
1
Add a comment...
 
TCT 2016 Featured Slides: FDA Perspectives on TAVR Label Expansion, and New and Iterative Device Approval Pathways http://buff.ly/2hdaCZw
1
Add a comment...
 
With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Ultimately the decision between the two strategies comes down to operator comfort and what is on formulary, an expert says. #cardiovascular #interventional

https://www.tctmd.com/news/no-rcts-propensity-score-matched-analysis-informs-choice-between-cangrelor-and-gpis-cath-lab
New research combining patient outcomes from the CHAMPION trials shows similar ischemic risk and less risk-adjusted bleeding with cangrelor compared with clopidogrel plus glycoprotein IIb/IIIa inhibitors (GPIs) in patients undergoing PCI. While the researchers are confident these findings cement ...
1
Add a comment...
 
Editorial perspective: Interventional Treatment of Atrial Fibrillation: Current Strategy and Unmet Needs http://buff.ly/2h3k7y4
1
Add a comment...
 
Happening NOW: Live webcast on Emerging Techniques in Mitral Valve Surgery. Join Drs. Argenziano, Borger & George http://buff.ly/2ggS8Hg
1
Add a comment...
 
Hold the tPA? Study Probes Necessity of IV Thrombolysis Prior to Endovascular Therapy for Acute Stroke

The post hoc study should be interpreted cautiously, because it compares “apples and oranges,” one expert says. #cardiovascular #stroke #cardiology

https://www.tctmd.com/news/hold-tpa-study-probes-necessity-iv-thrombolysis-prior-endovascular-therapy-acute-stroke
Hold the tPA? Study Probes Necessity of IV Thrombolysis Prior to Endovascular Therapy for Acute. Standard practice dictates that all eligible patients receive IV thrombolysis before undergoing endovascular treatment of an acute ischemic stroke caused by a large vessel occlusion, but a new analysis of ...
1
Add a comment...
 
Happening now! Drs. Mintz, Maehara & Jeremias discuss Use of Imaging/Physiology in CHIP Ask the panel a question: http://buff.ly/2h5qaid
1
Add a comment...
 
Noncardiac Surgery May Be Safe Earlier After PCI Than Previously Thought

Data from a large Swedish registry appear reassuring for those headed for the operating room within months of a DES.

https://www.tctmd.com/news/noncardiac-surgery-may-be-safe-earlier-after-pci-previously-thought
Despite guideline recommendations to avoid surgery for six months to a year after coronary artery stenting with a DES, the majority of patients are no more likely to die or suffer an MI than patients without heart disease as long as 30 days has passed. If a new Swedish registry study is any ...
1
Add a comment...
 
TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications: A new CME Webcast http://buff.ly/2gNy3vt
1
Add a comment...
 
New CME Program: Key Design Criteria for True Next Generation DES. http://buff.ly/2hdbJrX
1
Add a comment...
Story
Tagline
The Source for Interventional Cardiovascular News and Education
Introduction
TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine. 

TCTMD is produced and administered by the Cardiovascular Research Foundation. CRF's mission is to strive to improve the quality of life for patients with cardiovascular disease. The organization's goal is to advance the development and use of safe and effective minimally invasive cardiovascular treatments.
Contact Information
Contact info
Address
1700 Broadway, New York, NY 10019